EGF receptor plays an important role in glioma progression and TMZ resistance by activating Ras/Raf/mitogen-activated protein kinase (MAPK) or phosphoinositide-3 kinase/AKT/mammalian target of rapamycin signaling45. Here, AKT1 is linked to central nervous system cancer.